Tumori Journal – Author's Insight A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
1 pistes • 0 écoutes • 0 favoris
Tumori Journal – Author's Insight A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
Andaaz Suhan
0:006:47
Knowledge
Épisodes
1
Tumori Journal – Author's Insight A phase 2 study of cabozantinib for advanced renal cell carcinoma after immune-checkpoint inhibitors: the BREAKPOINT trial
Andaaz Suhan